Leeper F J
University Chemical Laboratory, Cambridge, UK.
Ciba Found Symp. 1994;180:111-23; discussion 124-30. doi: 10.1002/9780470514535.ch7.
In the course of the cyclization of the linear tetrapyrrole hydroxymethylbilane to uroporphyrinogen III, catalysed by uroporphyrinogen III synthase (cosynthase), ring D of the bilane becomes inverted. Many different mechanisms have been proposed for this transformation but the most economical is one involving a spirocyclic pyrrolenine. Synthesis of a spirolactam, and other compounds closely related to the spirocyclic pyrrolenine, has shown that such compounds are not impossibly strained. The spirolactam is a powerful inhibitor of the enzyme, which suggests it does resemble an intermediate in the enzymic process. In the synthetic procedure to make an ester of the spirolactam the two products obtained were initially thought to be conformational isomers. However, molecular mechanics calculations on a model of the spirolactam predicted that several low energy conformations should exist and that the energy barriers for their interconversion are all lower than 32 kJ/mol. Reinvestigation revealed that one of the two products is in fact a macrocyclic dimer with a 28-membered ring. On the basis of the predicted preferred conformations of the spirolactam and of uroporphyrinogen III, a detailed three-dimensional mechanism is proposed, along with a rationalization of how the rearrangement of ring D may be directed by the enzyme.
在由尿卟啉原III合酶(协同合酶)催化的线性四吡咯羟甲基胆色素原环化形成尿卟啉原III的过程中,胆色素原的D环发生了倒转。针对这种转化已经提出了许多不同的机制,但最合理的是涉及螺环吡咯啉的机制。螺内酰胺以及与螺环吡咯啉密切相关的其他化合物的合成表明,这类化合物并非具有不可承受的张力。该螺内酰胺是该酶的一种强效抑制剂,这表明它确实类似于酶促过程中的一种中间体。在制备螺内酰胺酯的合成过程中,最初认为得到的两种产物是构象异构体。然而,对螺内酰胺模型进行的分子力学计算预测,应该存在几种低能量构象,并且它们相互转化的能垒均低于32 kJ/mol。重新研究发现,两种产物中的一种实际上是具有28元环的大环二聚体。基于预测的螺内酰胺和尿卟啉原III的优选构象,提出了一种详细的三维机制,以及关于D环重排如何由酶引导的一种合理解释。